Spontaneous clearance of hepatitis C virus in an interleukin 28B favorable genotype highly prevalent area

from the first reference is, ‘‘Undifferentiated and differentiated MSC do not elicit alloreactive lymphocyte proliferative responses and modulate immune responses. The findings support that MSC can be transplantable between HLA-incompatible individuals.’’ The abstract of the second reference mentions, ‘‘In vitro data suggest that MSCs have low inherent immunogenicity as they induce little, if any, proliferation of allogeneic lymphocytes. Instead, MSCs appear to be immunosuppressive in vitro. They inhibit T-cell proliferation to alloantigens and mitogens and prevent the development of cytotoxic T-cells. In vivo, MSCs prolong skin allograft survival and have several immunomodulatory effects, which are presented and discussed in the present study. Possible clinical applications include therapy-resistant severe acute graft-versus-host disease, tissue repair, treatment of rejection of organ allografts and autoimmune disorders.’’

[1]  S. Ray,et al.  Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution , 2012, Hepatology.

[2]  David B. Goldstein,et al.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus , 2009, Nature.

[3]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[4]  Sheng-Nan Lu,et al.  Identified cases of acute hepatitis C from computerized laboratory database: a hospital-based epidemiological and clinical study. , 2008, The Journal of infection.

[5]  A. Nauta,et al.  Immunomodulatory properties of mesenchymal stromal cells. , 2007, Blood.

[6]  A. Uccelli,et al.  Mesenchymal stem cells: a new strategy for immunosuppression? , 2007, Trends in immunology.

[7]  J. Kaldor,et al.  Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies , 2006, Journal of viral hepatitis.

[8]  J. Kaldor,et al.  Clearance of hepatitis C virus after newly acquired infection in injection drug users. , 2004, The Journal of infectious diseases.

[9]  N. Gruener,et al.  Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. , 2003, Gastroenterology.

[10]  J. Spivak,et al.  Polycythemia vera: myths, mechanisms, and management. , 2002, Blood.

[11]  Chien-Jen Chen,et al.  Persistent hyperendemicity of hepatitis C virus infection in Taiwan: The important role of iatrogenic risk factors , 2001, Journal of medical virology.

[12]  C. Changchien,et al.  Excess mortality from hepatocellular carcinoma in an HCV-endemic township of an HBV-endemic country (Taiwan). , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.